1. Browne P, Chandaratna D, Angood C. Atlas of multiple sclerosis 2014. Neurology 2014;83:1022-4.

2. Melcon MO, Melcon CM, Bartoloni L, Cristiano E, Duran JC, Grzesiuk AK, Cabrera Gomez JA. Towards establishing MS prevalence in Latin America and the Caribbean. Mult Scler 2013;19:145-52.

3. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis: review and recommendations for clinical research. Arch Neurol 1990;47:98-104.

4. Depression. Available from: [Last accessed on 29 Mar 2018].

5. Koch MW, Patten S, Berzins S, Zhornitsky S, Greenfield J, Wall W, Metz LM. Depression in multiple sclerosis: a long term longitudinal study. Mult Scler J 2015;21:76-82.

6. Alhazzani AA, Alqahtani MS, Ogran H, Abuhawi OH, Asiri AY, Al-Hanash AM, AlQahtany RA, Alfaifi AA, Asiri AA, Asiri MA. Depression severity and its predictors among multiple sclerosis patients in Saudi Arabia: a cross-sectional study. Neuroimmunol Neuroinflammation 2018;5:8.

7. Bohlega S, Inshasi J, Tahan ARA, Madani AB, Qahtani H, Rieckmann P. Multiple sclerosis in the Arabian gulf countries: a consensus statement. J Neurol 2013;260:2963.

8. Alter M, Leiboweitz U, Speer J. Risk of multiple sclerosis related to age at immigration to Israel. Arch Neurol 1966;15:234-7.

9. Rivera VM. Multiple sclerosis as a universal disease and the challenges to immigrants in high prevalence countries. Eur J Neurol 2018;1:701.

Neuroimmunology and Neuroinflammation
ISSN 2349-6142 (Online) 2347-8659 (Print)


All published articles are preserved here permanently:


All published articles are preserved here permanently: